Does chronic stress suppress hypothalamic GnRH pulsatility and reduce ovarian estradiol and androgen production?

Chronic stress activates the hypothalamic-pituitary-adrenal (HPA) axis, initiating a physiological cascade that disrupts the hypothalamic-pituitary-gonadal (HPG) axis. This neuroendocrine inhibition is most prominently observed in functional hypothalamic amenorrhea (FHA), where systemic stress suppresses reproductive function.

Mechanistic explanations

• Central GnRH suppression: Elevated levels of corticotropin-releasing hormone (CRH), beta-endorphins, and glucocorticoids directly inhibit the hypothalamic GnRH pulse generator. This occurs through the downregulation of upstream stimulatory kisspeptin (KISS1) neurons and the upregulation of inhibitory RFamide-related peptide-3 (RFRP-3, the mammalian ortholog of gonadotropin-inhibitory hormone or GnIH) in the dorsomedial hypothalamus.
• Pituitary gonadotropin disruption: Because the anterior pituitary requires precise, pulsatile GnRH stimulation to synthesize and secrete gonadotropins, the loss of GnRH pulsatility directly dampens luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion.
• Ovarian steroidogenic impairment: Deprived of adequate LH and FSH support, ovarian follicles fail to mature properly. Additionally, local ovarian RFRP-3 signaling acts on GPR147 receptors to downregulate critical steroidogenic enzymes, including steroidogenic acute regulatory protein (StAR) and aromatase (CYP19A1), which severely compromises the conversion of cholesterol into androgens and estradiol.

Clinical evidence and implications

• Gonadotropin dynamics: Clinical evaluations of individuals with stress-induced FHA show low-to-normal LH and FSH levels, but a profound loss of LH pulse frequency (often falling below the normal ~1 pulse per hour in the follicular phase) and amplitude.
• Hormonal output: Circulating levels of estradiol are typically suppressed to postmenopausal levels (<20–30 pg/mL), and ovarian androgens (such as testosterone and androstenedione) are significantly reduced.
• Systemic consequences: In women of reproductive age, this chronic hypoestrogenic state leads to compromised bone mineral density (increased fracture risk), endothelial dysfunction, and impaired psychosexual well-being.

Bottom line

Chronic stress physiology directly suppresses hypothalamic GnRH pulsatility and downregulates upstream kisspeptin while activating inhibitory RFRP-3. This central disruption reduces pituitary LH/FSH secretion and impairs ovarian follicular steroidogenesis, ultimately leading to clinical hypoestrogenism and suppressed androgen production.